MBOT — Microbot Medical Income Statement
0.000.00%
Last trade - 00:00- $90.58m
- $60.19m
- 46
- 23
- 97
- 56
Annual income statement for Microbot Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.09 | 11.4 | 13.3 | 11 | 11.6 |
| Operating Profit | -9.09 | -11.4 | -13.3 | -11 | -11.6 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -9.17 | -11.3 | -13.2 | -10.7 | -11.4 |
| Net Income After Taxes | -9.17 | -11.3 | -13.2 | -10.7 | -11.4 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.17 | -11.3 | -13.2 | -10.7 | -11.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.17 | -11.3 | -13.2 | -10.7 | -11.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.29 | -1.59 | -1.81 | -0.944 | -0.661 |